Attached files

file filename
EX-31 - EXHIBIT 31.2 - Hydrodynex, Inc.ex312apg.htm
EX-32 - EXHIBIT 32.1 - Hydrodynex, Inc.ex321apg.htm
EX-32 - EXHIBIT 32.2 - Hydrodynex, Inc.ex322apg.htm
EX-31 - EXHIBIT 31.1 - Hydrodynex, Inc.ex311apg.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

 

[X]

Quarterly report pursuant Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended December 31, 2009.

 

 

[  ]

Transition report pursuant Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from _______ to _______.


000-53506

(Commission file number)


[hdyx10q_123109apg001.jpg] 

HYDRODYNEX, INC.

(Exact name of small business issuer as specified in its charter)

 

Nevada

20-4903071

702-722-9406

(State or other jurisdiction

(IRS Employer

(Registrant’s telephone number)

of incorporation or organization)

Identification No.)

 

 

 

 

 

230 Bethany Rd. #128; Burbank, CA 91504

(Address of principal executive offices)

 

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes [X]  No [  ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer [  ]

Accelerated filer [  ] 

Non-accelerated filer [  ] 

Smaller reporting company [X]

(Do not check if a smaller reporting company)

 


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [X] No [  ]


On February 11, 2010, there were 1,973,880 outstanding shares of the registrant's common stock, par value $.001 per share.





TABLE OF CONTENTS


PART I – FINANCIAL INFORMATION

 

3

Item 1.

Financial Statements

 

3

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

22

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

27

Item 4.

Controls and Procedures

 

27

PART II – OTHER INFORMATION

 

28

Item 1.

Legal Proceedings

 

28

Item 1A.

Risk Factors

 

28

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

28

Item 3.

Defaults Upon Senior Securities

 

28

Item 4.

Submission of Matters to a Vote of Security Holders

 

28

Item 5.

Other Information

 

28

Item 6.

Exhibits

 

29

SIGNATURES

 

 

29

 



- 2 -



PART I – FINANCIAL INFORMATION


Item1. Financial Statements


Hydrodynex, Inc.

(A Development Stage Company)

December 31, 2009 and 2008

Index to Financial Statements


CONTENTS

Page

Balance Sheets at December 31, 2009 (Unaudited) and June 30, 2009

4

Statements of Operations for the Three and Six Months Ended December 31, 2009 and 2008 and for the Period from May 12, 2006 (Inception) through December 31, 2009 (Unaudited)

5

Statement of Stockholders’ Equity (Deficit) for the Period from May 12, 2006 (Inception) through December 31, 2009  (Unaudited)

6-7

Statements of Cash Flows for the Six Months Ended December 31, 2009 and 2008 and for the Period from May 12, 2006 (Inception) through December 31, 2009 (Unaudited)

8

Notes to the Financial Statements (Unaudited)

9-21



- 3 -



Hydrodynex, Inc.

 (A Development Stage Company)

 Balance Sheets

 

 

 

 

 

 

 

December 31, 2009

 

 

June 30, 2009

 

 

 

 

 

 

 

(Unaudited)

 

 

 

 

 Assets

 

 

 

 

 

 

 

 Current Assets

 

 

 

 

 

 

 

 

 Cash

 

 $

8,892 

 

75 

 

 

 Advance on purchases

 

 

26,991 

 

 

26,991 

 

 

 

 Total Current Assets

 

 

35,883 

 

 

27,066 

 

 

 

 

 

 

 

 

 

 

 

 

 Office Equipment

 

 

 

 

 

 

 

 

 Office equipment  

 

 

1,288 

 

 

1,288 

 

 

 Less: Accumulated depreciation

 

 

(436)

 

 

(307)

 

 

 

 

 

 

 

 

 

 

 

 

 Office Equipment, net

 

 

852 

 

 

981 

 

 

 

 

 

 

 

 

 

 

 

 

 Other Assets

 

 

 

 

 

 

 

 

 Prepaid patent application costs

 

 

6,997 

 

 

6,997 

 

 

 Deferred license fees

 

 

68,175 

 

 

68,175 

 

 

 

 Total Other Assets

 

 

75,172 

 

 

75,172 

 

 

 

 

 

 

 

 

 

 

 

 

 Total Assets

 

 $

111,907 

 

103,219 

 

 

 

 

 

 

 

 

 

 

 

 

 Liabilities and Stockholders' Equity (Deficit)

 

 

 

 

 

 

 

 Current Liabilities:

 

 

 

 

 

 

 

 

 Accounts payable

 

 $

12,532 

 

27,824 

 

 

 Accrued expenses

 

 

2,251 

 

 

8,000 

 

 

 Accrued expenses - related party

 

 

37,600 

 

 

30,100 

 

 

 Accrued interest

 

 

 

 

870 

 

 

 Notes payable - related party

 

 

3,440 

 

 

 

 

 Convertible notes payable, net of financing cost

 

 

 

 

11,688 

 

 

 

 Total Current Liabilities

 

 

55,823 

 

 

78,482 

 

 

 

 

 

 

 

 

 

 

 

 

 License Fees Payable

 

 

28,660 

 

 

28,096 

 

 

 

 

 

 

 

 

 

 Total Liabilities

 

 

84,483 

 

 

106,578 

 

 

 

 

 

 

 

 

 

 

 

 

 Stockholders Equity (Deficit)

 

 

 

 

 

 

 

 Preferred stock, $.001 par value, 5,000,000 shares authorized:

 

 

 

 

 

 

 

 

 none issued or outstanding

 

 

 

 

 

 Common stock, $.001 par value, 75,000,000 shares authorized,  

 

 

 

 

 

 

 

 

 1,973,880 and 1,765,000 shares issued and outstanding, respectively

 

1,974 

 

 

1,765 

 

 Additional paid-in capital

 

 

219,636 

 

 

167,625 

 

 Deficit accumulated during the development stage

 

 

(194,186)

 

 

(172,749)

 

 

 

 

 

 

 

 

 

 

 

 

 Total Stockholders' Equity (Deficit)

 

 

27,424 

 

 

(3,359)

 

 

 

 

 

 

 

 

 

 

 

 

 Total Liabilities and Stockholders' Equity (Deficit)

 

 $

111,907 

 

103,219 

 

 

 

 

 

 

 

 

 

 

 

 

 See accompanying notes to the financial statements.



- 4 -



Hydrodynex, Inc.

 (A Development Stage Company)

 Statements of Operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 For the

 

 

 

 

 

 

 

 For the

Three Months

 

 

 For the

Three Months

 

 

 For the

Six Months

 

 

 For the

Six Months

 

 

Period from

May 12, 2006

 

 

 

 

 

 

 

 Ended

 

 

 Ended

 

 

 Ended

 

 

 Ended

 

 

 (inception) through

 

 

 

 

 

 

 

December 31,

2009

 

 

December 31,

2008

 

 

December 31,

2009

 

 

December 31,

2008

 

 

December 31,

2009

 

 

 

 

 

 

 

 (Unaudited)

 

 

 (Unaudited)

 

 

 (Unaudited)

 

 

 (Unaudited)

 

 

 (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 NET REVENUES

 

 $

 

 

 

 $

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 COST OF GOODS SOLD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 GROSS PROFIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 OPERATING EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Advertising and promotion

 

 

 

 

 

 

 

 

 

 

5,429 

 

 

 Consulting fees

 

 

 

 

7,500 

 

 

7,500 

 

 

15,000 

 

 

61,000 

 

 

 Depreciation

 

 

65 

 

 

65 

 

 

130 

 

 

129 

 

 

437 

 

 

 Board of directors fees

 

 

 

 

 

 

 

 

 

 

2,750 

 

 

 General and administrative

 

 

4,396 

 

 

2,643 

 

 

4,642 

 

 

3,830 

 

 

16,315 

 

 

 Legal and accounting

 

 

8,125 

 

 

11,205 

 

 

16,750 

 

 

33,586 

 

 

100,283 

 

 

 Travel

 

 

 

 

 

 

70 

 

 

34 

 

 

10,996 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Total Operating Expenses

 

 

12,586 

 

 

21,413 

 

 

29,092 

 

 

52,579 

 

 

197,210 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 LOSS FROM OPERATIONS

 

 

(12,586)

 

 

(21,413)

 

 

(29,092)

 

 

(52,579)

 

 

(197,210)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 OTHER (INCOME) EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Foreign currency transactions (gain) loss

 

(524)

 

 

(1,408)

 

 

564 

 

 

(6,808)

 

 

1,862 

 

 

 Interest expense

 

 

 

 

808 

 

 

402 

 

 

1,398 

 

 

3,735 

 

 

 Forgiveness of debt

 

 

 

 

 

 

(8,621)

 

 

 

 

(8,621)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Total Other (Income) Expenses

 

 

(524)

 

 

(600)

 

 

(7,655)

 

 

(5,410)

 

 

(3,024)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 LOSS BEFORE TAXES

 

 

(12,062)

 

 

(20,813)

 

 

(21,437)

 

 

(47,169)

 

 

(194,186)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 INCOME TAX PROVISION

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 NET LOSS

 

 $

(12,062)

 

(20,813)

 

(21,437)

 

 $

(47,169)

 

(194,186)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 NET LOSS PER COMMON SHARE -  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 BASIC AND DILUTED:

 

 $

(0.01)

 

(0.01)

 

(0.01)

 

 $

(0.03)

 

(0.16)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Weighted Common Shares Outstanding -  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 basic and diluted

 

 

1,913,010 

 

 

1,505,870 

 

 

1,850,084 

 

 

1,502,935 

 

 

1,197,091 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 See accompanying notes to the financial statements.



- 5 -



Hydrodynex, Inc.

(A Development Stage Company)

Statement of Stockholders' Equity (Deficit)

For the Period from May 12, 2006 (Inception) through December 31, 2009

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Common Stock, $0.001 Par Value

 

 Additional

 

 Deficit accumulated

 

 Total

 

 

 

 

 Number of

 

 

 

 

 Paid-in

 

 During the

 

 Stockholders'

 

 

 

 

 Shares

 

 Amount

 

 Capital

 

 Development Stage

 

 Equity (Deficit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Balance, May 12, 2006 (inception)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Shares issued to President for cash

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 at $0.01 per share upon formation

 

200,000 

 

 

200 

 

 

1,800 

 

 

 

 

 

2,000 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Net loss

 

 

 

 

 

 

 

 

 

 

(536)

 

 

(536)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Balance, June 30, 2006

 

200,000 

 

 

200 

 

 

1,800 

 

 

(536)

 

 

1,464 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Shares issued to President for cash

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 at $0.01 per share

 

300,000 

 

 

300 

 

 

2,700 

 

 

 

 

 

3,000 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Net loss

 

 

 

 

 

 

 

 

 

 

(1,296)

 

 

(1,296)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Balance, June 30, 2007

 

500,000 

 

 

500 

 

 

4,500 

 

 

(1,832)

 

 

3,168 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Shares issued for cash at $0.10 per share

 

1,000,000 

 

 

1,000 

 

 

99,000 

 

 

 

 

 

100,000 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Options issued for director fees

 

 

 

 

 

 

 

2,750 

 

 

 

 

 

2,750 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Options issued for services

 

 

 

 

 

 

 

1,500 

 

 

 

 

 

1,500 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Net loss

 

 

 

 

 

 

 

 

 

 

(84,454)

 

 

(84,454)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Balance, June 30, 2008

 

1,500,000 

 

 

1,500 

 

 

107,750 

 

 

(86,286)

 

 

22,964 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Common stock issued in connection with sale

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 of security units for cash at $0.50 per unit

 

15,000 

 

 

15 

 

 

4,185 

 

 

 

 

 

4,200 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Warrants issued in connection with sale

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 of security units for cash at $0.50 per unit

 

 

 

 

 

 

 

3,300 

 

 

 

 

 

3,300 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Warrants issued in connection with

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 issuance of convertible notes payable

 

 

 

 

 

 

 

2,640 

 

 

 

 

 

2,640 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Shares issued for cash at $0.50 per share

 

250,000 

 

 

250 

 

 

49,750 

 

 

 

 

 

50,000 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Net loss

 

 

 

 

 

 

 

 

 

 

(86,463)

 

 

(86,463)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Balance, June 30, 2009

 

1,765,000 

 

 

1,765 

 

 

167,625 

 

 

(172,749)

 

 

(3,359)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



- 6 -


CONTINUED...

 Common stock issued for conversion of notes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 payable on July 25, 2009 at $0.25 per share

 

17,280 

 

 

17 

 

 

4,303 

 

 

 

 

 

4,320 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Common stock issued for conversion of notes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 payable on August 23, 2009 at $0.25 per share

21,600 

 

 

22 

 

 

5,378 

 

 

 

 

 

5,400 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Common stock issued in connection with sale

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 of security units for cash at $0.25 per unit

 

30,000 

 

 

30 

 

 

7,470 

 

 

 

 

 

7,500 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Shares issued for cash at $0.25 per share

 

140,000 

 

 

140 

 

 

34,860 

 

 

 

 

 

35,000 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Net loss

 

 

 

 

 

 

 

 

 

 

(21,437)

 

 

(21,437)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Balance, December 31, 2009

 

1,973,880 

 

1,974 

 

219,636 

 

(194,186)

 

27,424 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 See accompanying notes to the financial statements.




- 7 -



Hydrodynex, Inc.

 (A Development Stage Company)

 Statements of Cash Flows

 

 

 

 

 

 

 

 

 

 

 

 

 For the Period from

 

 

 

 

 

 

 

 For the Six Months

 

 

 For the Six Months

 

 

May 12, 2006

 

 

 

 

 

 

 

 Ended

 

 

 Ended

 

 

 (inception) through

 

 

 

 

 

 

 

December 31, 2009

 

 

December 31, 2008

 

 

December 31, 2009

 

 

 

 

 

 

 

 (Unaudited)

 

 

 (Unaudited)

 

 

 (Unaudited)

 

 CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 Net Loss

 

 

 $

(21,437)

 

(47,169)

 

(194,186)

 

 Adjustments to reconcile net loss to net cash

 

 

 

 

 

 

 

 

 

 

 

 used in operating activities

 

 

 

 

 

 

 

 

 

 

 

 Depreciation expense

 

 

129 

 

 

129 

 

 

436 

 

 

 Amortization of discount on convertible notes payable

 

 

312 

 

 

1,008 

 

 

 

 

 Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 Prepaid expenses

 

 

 

 

750 

 

 

 

 

 

 Advances on purchases

 

 

 

 

 

 

(26,991)

 

 

 

 Prepaid patent applications costs

 

 

 

 

 

 

(6,997)

 

 

 

 Deferred license fees

 

 

 

 

 

 

(68,175)

 

 

 

 Accounts payable and accrued expenses

 

 

(21,042)

 

 

7,410 

 

 

14,782 

 

 

 

 Interest payable

 

 

(870)

 

 

 

 

 

 

 

 License fees payable

 

 

564 

 

 

(6,808)

 

 

28,660 

 

 NET CASH USED IN OPERATING ACTIVITIES

 

 

(42,344)

 

 

(44,680)

 

 

(252,471)

 

 CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 Investment in office equipment

 

 

 

 

 

 

(1,288)

 

 NET CASH USED IN INVESTING ACTIVITIES

 

 

 

 

 

 

(1,288)

 

 CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 Accrued expenses - related party

 

 

7,500 

 

 

15,100 

 

 

37,600 

 

 

 Proceeds from note payable - related party

 

 

3,440 

 

 

11,975 

 

 

3,440 

 

 

 Repayment of note payable - related party

 

 

(2,000)

 

 

(2,000)

 

 

 

 

 Proceeds from convertible notes payable

 

 

 

 

12,000 

 

 

 

 

 Repayment of convertible notes payable

 

 

(10,000)

 

 

 

 

 

 

 Proceeds from sale of common stock and warrants

 

 

52,220 

 

 

7,500 

 

 

221,610 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 NET CASH PROVIDED BY FINANCING ACTIVITIES

 

 

51,160 

 

 

44,575 

 

 

262,650 

 

 NET CHANGE IN CASH

 

 

8,816 

 

 

(105)

 

 

8,891 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Cash, Beginning of Period

 

 

75 

 

 

518 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Cash, End of Period

 

 $

8,891 

 

413 

 

8,891 

 

 SUPPLEMENTAL DISCLOSURE OF

 

 

 

 

 

 

 

 

 

 

 

 CASH FLOWS INFORMATION:

 

 

 

 

 

 

 

 

 

 

 

 Interest paid

 

 $

402 

 

 

3,735 

 

 

 Income tax paid

 

 $

 

 

 

 NON-CASH FINANCING AND INVESTING TRANSACTIONS:

 

 

 

 

 

 

 

 

 

 

 

 Warrants issued in connection with issuance of convertible debt

 

 $

 

 

2,640 

 

2,640 

 

 

 Common shares issued for conversion of convertible notes payable

 $

9,000 

 

 

 

9,000 

 

 

 Common shares issued for conversion of interests payable

 

 $

720 

 

 

 

720 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 See accompanying notes to the financial statements.



- 8 -


Hydrodynex, Inc.

(A Development Stage Company)

December 31, 2009 and 2008

Notes to the Financial Statements

(Unaudited)


NOTE 1 - ORGANIZATION AND OPERATIONS


Hydrodynex, Inc. (a development stage company) (“Hydrodynex” or the “Company”) was incorporated on May 12, 2006 under the laws of the State of Nevada for the purpose of marketing and distribution of AO-System (Anodic Oxidation) water treatment units under an exclusive license agreement for the Territory of North America Comprising United States, Canada and Mexico.


NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Basis of presentation


The accompanying unaudited interim financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented.  Unaudited interim results are not necessarily indicative of the results for the full year.  These unaudited interim financial statements should be read in conjunction with the financial statements of the Company for the fiscal year ended June 30, 2009 and notes thereto contained in the information as part of the Company’s Annual Report on Form 10-K filed with the SEC on October 13, 2009.


Reclassification


Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation.   These reclassifications had no effect on reported losses.


Development stage company


The Company is a development stage company as defined by section 915-10-20 of the FASB Accounting Standards Codification.  The Company is still devoting substantially all of its efforts on establishing the business and its planned principal operations have not commenced.  All losses accumulated since inception have been considered as part of the Company’s development stage activities.


Use of estimates


The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful life of office equipment and the future manufacturing of AO-System by the Company to recover prepaid patent costs and deferred license fees.  Actual results could differ from those estimates.


Fiscal year


The Company elected June 30 as its fiscal year ending date upon formation.


Cash equivalents


The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.


Advance on purchases


 

- 9 -


Advance on purchases primarily represents amounts paid to the vendor for future delivery of products, all of which were fully or partially refundable depending upon the terms and conditions of the purchase agreements.


Office equipment


Office equipment is recorded at cost. Expenditures for major additions and betterments are capitalized.  Maintenance and repairs are charged to operations as incurred. Depreciation of office equipment is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years.  Upon sale or retirement of office equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in statements of operations.


Prepaid patent application costs


The Company has adopted the guidelines as set out in paragraph 350-30-25-3 and paragraph 350-30-35-6 of the FASB Accounting Standards Codification for prepaid patent application costs.  Under the requirements as set out in paragraph 350-30-25-3 and paragraph 350-30-35-6 of the FASB Accounting Standards Codification, the Company capitalizes and amortizes patent application costs associated with the licensed product the Company intends to sell pursuant to the Exclusive License Agreement, entered into on September 3, 2007, over their remaining legal lives, estimated useful lives, or the term of the contract, whichever is shorter.  All internally developed process costs incurred to the point when a patent application is to be filed are expensed as incurred and classified as research and development costs.  Patent application costs, generally legal costs, thereafter incurred, are capitalized pending disposition of the individual patent application, and are subsequently either amortized based on the initial patent life granted, generally fifteen (15) to twenty (20) years for domestic patents and five (5) to twenty (20) years for foreign patents, or expensed if the patent application is rejected.  The costs of defending and maintaining patents are expensed as incurred.  Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.


Deferred license fees


The Company has adopted the guidelines as set out in paragraph 350-30-25-3 and paragraph 350-30-35-6 of the FASB Accounting Standards Codification for deferred license fees.  Under the requirements as set out in paragraph 350-30-25-3 and paragraph 350-30-35-6, the Company records all non-refundable license fees in connection with the Exclusive License Agreement, entered into on September 3, 2007, as deferred license fees recoupable from the future Product Royalty, which is in perpetuity at ten percent (10%) of the Net Selling Price on all AO water treatment systems assembled or manufactured by the Company or a subcontract manufacture utilized by the Company and paid for by customers of the Company as the Company is in the development stage and intends to manufacture or assemble the AO-System upon the AO-System being certified and approved by the United States Environmental Protection Agency (“EPA”) for sale on a commercial basis in the United States.  The Company will amortize deferred license fees upon commencement of operations, over the remaining legal life of the patent of the AO System, or the estimated useful life, or the term of the contract, whichever is shorter.  The Company will expend deferred license fees as license fees in the event that the Company decides not to manufacture or assemble the AO-System.


Impairment of long-lived assets


The Company follows paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets.  The Company’s long-lived assets, which include office equipment, prepaid patent application costs and deferred license fees for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.


The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts.  Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated or amortized over the newly determined remaining estimated useful lives.  The Company determined that there were no impairments of long-lived assets as of December 31, 2009 or 2008.


Fair value of financial instruments


The Company applies paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and has adopted paragraph 820-10-35-37 of the FASB Accounting Standards Codification to measure the fair value of its financial instruments.  Paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a fair value hierarchy which prioritizes the



- 10 -


inputs to valuation techniques used to measure fair value into three (3) broad levels.  The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.  The three (3) levels of fair value hierarchy defined by paragraph 820-10-35-37 of the FASB Accounting Standards Codification are described below:


Level 1

 

Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

 

 

 

Level 2

 

Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

 

 

 

Level 3

 

Pricing inputs that are generally observable inputs and not corroborated by market data.


The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, advance on purchase, accounts payable, accrued expenses and interest payable, approximate their fair values because of the short maturity of these instruments.  The Company’s convertible notes payable approximates the fair value of such instrument based upon management’s best estimate of interest rates that would be available to the Company for similar financial arrangement at December 31, 2009.


The Company does not have any assets or liabilities measured at fair value on a recurring or a non-recurring basis, consequently, the Company did not have any fair value adjustments for assets and liabilities measured at fair value at December 31, 2009 or 2008, nor gains or losses are reported in the statement of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date for the interim period then ended December 31, 2009, 2008 or for the period from May 12, 2006 (inception) through December 31, 2009.


Revenue recognition


The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition.  The Company recognizes revenue when it is realized or realizable and earned less estimated future doubtful accounts.  The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.


The Company will derive its revenue from sales contracts with customers with revenues being generated upon the shipment of goods upon the Company commencing operations.  Persuasive evidence of an arrangement is demonstrated via invoice, product delivery is evidenced by warehouse shipping log as well as a signed bill of lading from the trucking company or third party carrier and title transfers upon shipment, based on free on board (“FOB”) warehouse; the sales price to the customer is fixed upon acceptance of the purchase order and there is no separate sales rebate, discount, or volume incentive.


Foreign currency transactions


The Company applies the guidelines as set out in Section 830-20-35 of the FASB Accounting Standards Codification (Section 830-20-35) for foreign currency transactions.  Pursuant to Section 830-20-35 of the FASB Accounting Standards Codification, foreign currency transactions are transactions denominated in a currency other than U.S. Dollar, the Company’s functional currency.  Foreign currency transactions may produce receivables or payables that are fixed in terms of the amount of foreign currency that will be received or paid.  A change in exchange rates between the functional currency and the currency in which a transaction is denominated increases or decreases the expected amount of functional currency cash flows upon settlement of the transaction.  That increase or decrease in expected functional currency cash flows is a foreign currency transaction gain or loss that generally shall be included in determining net income for the period in which the exchange rate changes. Likewise, a transaction gain or loss (measured from the transaction date or the most recent intervening balance sheet date, whichever is later) realized upon settlement of a foreign currency transaction generally shall be included in determining net income for the period in which the transaction is settled.  The exceptions to this requirement for inclusion in net income of transaction gains and losses pertain to certain intercompany transactions and to transactions that are designated as, and effective as, economic hedges of net investments and foreign currency commitments.  Pursuant to Section 830-20-25 of the FASB Accounting Standards Codification, the following shall apply to all foreign currency transactions of an enterprise and its investees: (a) At the date the transaction is recognized, each asset, liability, revenue, expense, gain, or loss arising from the transaction shall be measured and recorded in the functional currency of the recording entity by use of the exchange rate in effect at that date as defined in section 830-10-20 of the FASB Accounting Standards Codification; and (b) At each balance sheet date, recorded balances that are denominated in a currency other than the functional currency of the recording entity shall be adjusted to reflect the current exchange rate.


Stock-based compensation for obtaining employee services and equity instruments issued to parties other than employees for acquiring goods or services


 

- 11 -


The Company accounted for its stock based compensation under the recognition and measurement principles of paragraph 718-10-30-3 of the FASB Accounting Standards Codification using the modified prospective method for transactions in which the Company obtains employee services in share-based payment transactions and paragraph 505-50-30-2 of the FASB Accounting Standards Codification for share-based payment transactions with parties other than employees.  All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the third-party performance is complete or the date on which it is probable that performance will occur.


The Company’s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.  Additionally, the Company’s policy is to issue new shares of common stock to satisfy stock option exercises.


The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model with weighted-average assumptions as discussed in each grant.  The ranges of assumptions for inputs for stock options issued under the 2006 Plan are as follows:


·  

The Company uses historical data to estimate employee termination behavior.  The expected life of options granted is determined using the simplified method as prescribed in paragraph 718-10-S99-1 of the FASB Accounting Standards Codification and represents the period of time the options are expected to be outstanding.


·  

The expected volatility is based on a combination of the historical volatility of the comparable companies’ stock over the contractual life of the options.


·  

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option.


·  

The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the option.


Income taxes


The Company accounts for income taxes under paragraph 710-10-30-2 of the FASB Accounting Standards Codification.  Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.  Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.


The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”).  Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.  The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of Section 740-10-25.


Commitments and contingencies


The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies.  Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.


Net loss per common share


Net loss per common share is computed pursuant to paragraph of 260-10-45-10 of the FASB Accounting Standards Codification.  Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period.  Diluted net loss per share is computed by dividing net loss by the weighted average number



- 12 -


of shares of common stock and potentially outstanding shares of common stock during each period to reflect the potential dilution that could occur from common shares issuable through stock options and warrants.


The following table shows the weighted-average number of potentially outstanding dilutive shares excluded from the diluted net loss per share calculation for the interim period ended December 31, 2009 and 2008 as they were anti-dilutive:


 

 

 

Weighted average number of

potentially outstanding dilutive shares

 

 

 

 

For the Interim Period Ended

December 31, 2009

 

 

For the Interim Period Ended

December 31, 2008

 

Stock options issued on June 30, 2008 under the 2006 Plan

 

 

 

70,000

 

 

 

70,000

 

 

 

 

 

 

 

 

 

 

 

Warrants issued in connection with the issuance of convertible notes payable issued between July 24, 2008 and August 23, 2008 with an exercise price of $1.00 per share and expiring three (3) years from the date of issuance

 

 

 

12,000

 

 

 

12,000

 

 

 

 

 

 

 

 

 

 

 

Warrants issued in connection with the sale of 15,000 shares of its common stock on November 25, 2008 with an exercise price of $1.00 per share and expiring three (3) years from the date of issuance

 

 

 

15,000

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

Total potentially outstanding dilutive shares

 

 

 

97,000

 

 

 

97,000

 


Cash flows reporting


The Company has adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by paragraph 230-10-45-24 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.


Recently issued accounting pronouncements  


In June 2003, the Securities and Exchange Commission (“SEC”) adopted final rules under Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”), as amended by SEC Release No. 33-9072 on October 13, 2009.  Under the provisions of Section 404 of the Sarbanes-Oxley Act, public companies and their independent auditors are each required to report to the public on the effectiveness of a company’s internal controls.  The smallest public companies with a public float below $75 million have been given extra time to design, implement and document these internal controls before their auditors are required to attest to the effectiveness of these controls.  This extension of time will expire beginning with the annual reports of companies with fiscal years ending on or after June 15, 2010.  Commencing with its annual report for the fiscal year ending June 30, 2010, the Company will be required to include a report of management on its internal control over financial reporting. The internal control report must include a statement


·  

of management’s responsibility for establishing and maintaining adequate internal control over its financial reporting;


·  

of management’s assessment of the effectiveness of its internal control over financial reporting as of year end; and


·  

of the framework used by management to evaluate the effectiveness of the Company’s internal control over financial reporting.


Furthermore, it is required to file the auditor’s attestation report separately on the Company’s internal control over financial reporting on whether it believes that the Company has maintained, in all material respects, effective internal control over financial reporting.


In June 2009, the FASB approved the “FASB Accounting Standards Codification” (the “Codification”) as the single source of authoritative nongovernmental U.S. GAAP to be launched on July 1, 2009.  The Codification does not change current U.S. GAAP, but is intended to simplify user access to all authoritative U.S. GAAP by providing all the authoritative literature related to a particular topic in one place.  All existing accounting standard documents will be superseded and all other accounting literature not included in the Codification will be considered non-authoritative. The Codification is effective for interim and

 

- 13 -


annual periods ending after September 15, 2009.  The Company does not expect the adoption to have a material impact on its consolidated financial position, results of operations or cash flows.


In August 2009, the FASB issued the FASB Accounting Standards Update No. 2009-04 “Accounting for Redeemable Equity Instruments - Amendment to Section 480-10-S99” which represents an update to section 480-10-S99, distinguishing liabilities from equity, per EITF Topic D-98, Classification and Measurement of Redeemable Securities.  The Company does not expect the adoption of this update to have a material impact on its consolidated financial position, results of operations or cash flows.


In August 2009, the FASB issued the FASB Accounting Standards Update No. 2009-05 “Fair Value Measurement and Disclosures Topic 820 – Measuring Liabilities at Fair Value”, which provides amendments to subtopic 820-10, Fair Value Measurements and Disclosures – Overall, for the fair value measurement of liabilities.  This update provides clarification that in circumstances in which a quoted price in an active market for the identical liability is not available, a reporting entity is required to measure fair value using one or more of the following techniques: 1. A valuation technique that uses: a. The quoted price of the identical liability when traded as an asset b. Quoted prices for similar liabilities or similar liabilities when traded as assets. 2. Another valuation technique that is consistent with the principles of topic 820; two examples would be an income approach, such as a present value technique, or a market approach, such as a technique that is based on the amount at the measurement date that the reporting entity would pay to transfer the identical liability or would receive to enter into the identical liability. The amendments in this update also clarify that when estimating the fair value of a liability, a reporting entity is not required to include a separate input or adjustment to other inputs relating to the existence of a restriction that prevents the transfer of the liability. The amendments in this update also clarify that both a quoted price in an active market for the identical liability when traded as an asset in an active market when no adjustments to the quoted price of the asset are required are Level 1 fair value measurements.  The Company does not expect the adoption of this update to have a material impact on its consolidated financial position, results of operations or cash flows.


In September 2009, the FASB issued the FASB Accounting Standards Update No. 2009-08 “Earnings Per Share – Amendments to Section 260-10-S99”,which represents technical corrections to topic 260-10-S99, Earnings per share, based on EITF Topic D-53, Computation of Earnings Per Share for a Period that includes a Redemption or an Induced Conversion of a Portion of a Class of Preferred Stock and EITF Topic D-42, The Effect of the Calculation of Earnings per Share for the Redemption or Induced Conversion of Preferred Stock. The Company does not expect the adoption of this update to have a material impact on its consolidated financial position, results of operations or cash flows.


In September 2009, the FASB issued the FASB Accounting Standards Update No. 2009-09 “Accounting for Investments-Equity Method and Joint Ventures and Accounting for Equity-Based Payments to Non-Employees”.  This update represents a correction to Section 323-10-S99-4, Accounting by an Investor for Stock-Based Compensation Granted to Employees of an Equity Method Investee. Additionally, it adds observer comment Accounting Recognition for Certain Transactions Involving Equity Instruments Granted to Other Than Employees to the Codification. The Company does not expect the adoption to have a material impact on its consolidated financial position, results of operations or cash flows.


In September 2009, the FASB issued the FASB Accounting Standards Update No. 2009-12 “Fair Value Measurements and Disclosures Topic 820 – Investment in Certain Entities That Calculate Net Assets Value Per Share (or Its Equivalent)”, which provides amendments to Subtopic 820-10, Fair Value Measurements and Disclosures-Overall, for the fair value measurement of investments in certain entities that calculate net asset value per share (or its equivalent). The amendments in this update permit, as a practical expedient, a reporting entity to measure the fair value of an investment that is within the scope of the amendments in this update on the basis of the net asset value per share of the investment (or its equivalent) if the net asset value of the investment (or its equivalent) is calculated in a manner consistent with the measurement principles of Topic 946 as of the reporting entity’s measurement date, including measurement of all or substantially all of the underlying investments of the investee in accordance with Topic 820. The amendments in this update also require disclosures by major category of investment about the attributes of investments within the scope of the amendments in this update, such as the nature of any restrictions on the investor’s ability to redeem its investments a the measurement date, any unfunded commitments (for example, a contractual commitment by the investor to invest a specified amount of additional capital at a future date to fund investments that will be make by the investee), and the investment strategies of the investees. The major category of investment is required to be determined on the basis of the nature and risks of the investment in a manner consistent with the guidance for major security types in U.S. GAAP on investments in debt and equity securities in paragraph 320-10-50-1B. The disclosures are required for all investments within the scope of the amendments in this update regardless of whether the fair value of the investment is measured using the practical expedient. The Company does not expect the adoption to have a material impact on its consolidated financial position, results of operations or cash flows.


In January 2010, the FASB issued the FASB Accounting Standards Update No. 2010-01 “Equity Topic 505 – Accounting for Distributions to Shareholders with Components of Stock and Cash”, which clarify that the stock portion of a distribution to shareholders that allows them to elect to receive cash or stock with a potential limitation on the total amount of cash that all shareholders can elect to receive in the aggregate is considered a share issuance that is reflected in EPS prospectively



- 14 -


and is not a stock dividend for purposes of applying Topics 505 and 260 (Equity and Earnings Per Share (“EPS”)).  Those distributions should be accounted for and included in EPS calculations in accordance with paragraphs 480-10-25- 14 and 260-10-45-45 through 45-47 of the FASB Accounting Standards codification.  The amendments in this Update also provide a technical correction to the Accounting Standards Codification.  The correction moves guidance that was previously included in the Overview and Background Section to the definition of a stock dividend in the Master Glossary.  That guidance indicates that a stock dividend takes nothing from the property of the corporation and adds nothing to the interests of the stockholders.  It also indicates that the proportional interest of each shareholder remains the same, and is a key factor to consider in determining whether a distribution is a stock dividend.


In January 2010, the FASB issued the FASB Accounting Standards Update No. 2010-02 “Consolidation Topic 810 – Accounting and Reporting for Decreases in Ownership of a Subsidiary – a Scope Clarification”, which provides amendments to Subtopic 810-10 and related guidance within U.S. GAAP to clarify that the scope of the decrease in ownership provisions of the Subtopic and related guidance applies to the following:


1.

A subsidiary or group of assets that is a business or nonprofit activity

2.

A subsidiary that is a business or nonprofit activity that is transferred to an equity method investee or joint venture

3.

An exchange of a group of assets that constitutes a business or nonprofit activity for a noncontrolling interest in an entity (including an equity method investee or joint venture).


The amendments in this Update also clarify that the decrease in ownership guidance in Subtopic 810-10 does not apply to the following transactions even if they involve businesses:


1.

Sales of in substance real estate.  Entities should apply the sale of real estate guidance in Subtopics 360-20 (Property, Plant, and Equipment) and 976-605 (Retail/Land) to such transactions.

2.

Conveyances of oil and gas mineral rights.  Entities should apply the mineral property conveyance and related transactions guidance in Subtopic 932-360 (Oil and Gas-Property, Plant, and Equipment) to such transactions.


If a decrease in ownership occurs in a subsidiary that is not a business or nonprofit activity, an entity first needs to consider whether the substance of the transaction causing the decrease in ownership is addressed in other U.S. GAAP, such as transfers of financial assets, revenue recognition, exchanges of non-monetary assets, sales of in substance real estate, or conveyances of oil and gas mineral rights, and apply that guidance as applicable. If no other guidance exists, an entity should apply the guidance in Subtopic 810-10.


Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.


NOTE 3 – GOING CONCERN


As reflected in the accompanying financial statements, the Company had a deficit accumulated during the development stage of $194,186 at December 31, 2009 and had a net loss and cash used in operations of $21,437 and $42,344 for the interim period ended December 31, 2009, respectively, with no revenues since inception.


While the Company is attempting to commence operations and generate revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations.  Management intends to raise additional funds by way of a public or private offering.  Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern.  While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect.  The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues.


The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.


NOTE 4 – ADVANCE ON PURCHASES


On February 22, 2008, the Company placed a purchase order to acquire an AO-System ® for Electrochemical Disinfection of Cold and Warm Drinking Water from Hydrosystemtechnik, GmbH for €35,250 (equivalent to $53,982 at February 22, 2008), 50% of which (€17,625) has been paid on February 25, 2008 and the remaining balance of (€17,625) was to be due and payable on November 30, 2009.  The Company is in negotiations for an extension of the due date with Hydrosystemtechnik, GmbH.


 

- 15 -


NOTE 5 – OFFICE EQUIPMENT


Office equipment, stated at cost, less accumulated depreciation at December 31, 2009 and June 30, 2009 consisted of the following:


 

Estimated Useful Life (Years)

 

December 31, 2009

 

 

June 30, 2009

 

Office equipment

5

 

1,288 

 

 

1,288 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,288 

 

 

 

1,288 

 

Less accumulated depreciation

 

 

 

(436)

 

 

 

(307)

 

 

 

 

852 

 

 

981 

 


Depreciation expense for the interim period ended December 31, 2009 and 2008 was $129 each, respectively.


NOTE 6 – EXCLUSIVE TECHNOLOGY LICENSE


On September 3, 2007 (“Effective Date”), the Company acquired an exclusive technology license (“Agreement”) for the Territory of North America, comprising Canada, the United States and Mexico to manufacture or assemble and market the AO-System water treatment system (AO – Anodic Oxidation) from Hydrosystemtechnik, GmbH (“Grantor”), a German corporation.  The Company has agreed to pay a licensing fee as follows: (i) €10,000 (equivalent to $13,635 at September 3, 2007) within 120 days of the  Effective Date; (ii) €20,000 (equivalent to $27,270 at September 3, 2007) on November 30, 2008; and (iii) €20,000 (equivalent to $27,270 at June 30, 2009) upon AO-System being certified and approved by the United States Environmental Protection Agency (“EPA”) for selling on a commercial basis in the United States, or €50,000 (equivalent to $68,175 at September 3, 2007) in aggregate, all of which are non-refundable and may be recouped from the future Product Royalty in perpetuity at ten percent (10%) of the Net Selling Price on all AO water treatment systems assembled or manufactured by the Company or a subcontract manufacture utilized by the Company and paid for by customers of the Company due and payable quarterly within 30 days from the last day of the quarter provided the Company exercises its right to manufacture or assemble AO-Systems.  In the event the Company does not manufacture or assemble AO-Systems, the Company pays no royalty on finished units purchased from GRANTOR and resold to customers of the Company, the license fees will no longer be considered prepaid royalties   and the Company will amortize prepaid royalties over the remaining legal life of the patent of AO System, or estimated useful life, or the term of the contract, whichever is shorter in the event that the Company decides not to manufacture or assemble AO-System.


The Company’s exclusive license right to sell finished AO Units in the territory is contingent upon the Company achieving minimum annual sales volume as defined in Table 1 of Appendix B of the Amended License Agreement (the “Agreement”) (filed as an exhibit to the company fling on Form 8-K dated September 5, 2008) among other terms and conditions at the end of each business year, beginning with the third (3 rd) anniversary after the effective date of the Agreement.  In the event the objectives defined in years three (3) through five (5) of Table 1 in Appendix B of the Agreement are not attained at the end of each business year, the Agreement shall, at the option of the GRANTOR, automatically revert to a non-exclusive marketing agreement and the Company will no longer have the right in manufacturing or assembling of AO Systems.


The Company determined that the (iii) payment required under the exclusive license agreement upon approval of U.S. EPA is a contractual liability instead of contingent liability as the AO system has been certified and approved by the European Union for selling on a commercial basis in Europe and the United States Environmental Protection Agency’s certification and approval for selling on a commercial basis in the United States is a matter of procedure and recorded deferred license fees and related license fees payable of $68,175, €50,000 measured in U.S. Dollar at September 3, 2007, the transaction date upon signing of the Exclusive License Agreement.


The Company paid the first installment of €10,000 with $14,892 on December 17, 2007 and the second installment of €20,000 due on November 30, 2008 and paid $26,486 on January 26, 2009, respectively.  The due date for the third installment of €20,000 was undeterminable pending EPA approval.


 

- 16 -


NOTE 7 – CONVERTIBLE NOTES PAYABLE


Convertible notes payable at December 31, 2009 and June 30, 2009 consisted of the following:

 

 

 

 

 

 

 

 

 

 

 

December 31, 2009

 

 

June 30, 2009

 

Convertible notes payable of $12,000 issued to individual note holders from July 24, 2008 through August 23, 2008 with simple interest at 8.00% per annum with principal and interest due one (1) year from the date of issuance, convertible to common stock at $0.50 per share inclusive of warrants to purchase 12,000 shares at $1.00 per share expiring three (3) year from the date of issuance, $3,000 of which along with accrued interest of $240 were repaid on September 2, 2009 and $9,000 of which along with accrued interest of $720 were converted to 38,880 shares of common stock at $0.25 per share when due.

 

$

-

 

 

$

12,000

 

 

 

 

 

 

 

 

 

 

Fair value of warrants issued in connection with issuance of convertible note payable

 

 

(2,640

)

 

 

(2,640

 

 

 

 

 

 

 

 

 

Accumulated amortization of the fair value of warrants

 

 

2,640

 

 

 

2,328

 

 

 

 

 

 

 

 

 

 

 

 

$

-

 

 

$

11,688

 


In connection with the issuance of convertible notes payable issued between July 24, 2008 and August 23, 2008, the Company issued warrants to purchase an aggregate of 12,000 shares of its common stock to the convertible note holders with an exercise price of $1.00 per share expiring three (3) years from the date of issuance, all of which have been earned upon issuance.  The fair value of these warrants granted, estimated on the date of grant, was $2,640, which has been recorded as a debit to financing cost and a credit to additional paid-in capital, using the Black-Scholes option-pricing model with the following weighted-average assumptions:


 

 

 

 

 

 

Expected option life (year)

 

 

 

3

 

Expected volatility

 

 

 

163.00%

 

Risk-free interest rate

 

 

 

3.23%

 

Dividend yield

 

 

 

0.00%

 


NOTE 8 – STOCKHOLDERS’ EQUITY (DEFICIT)


Issuance of common stock


The Company was incorporated on May 12, 2006.  In May 2006, 200,000 shares of its common stock were sold to the Company’s founder and President at $0.01 per share for $2,000 in cash.


During fiscal year 2007, the Company sold 300,000 shares of its common stock to the Company’s founder and President at $0.01 per share for $3,000 in cash.


During fiscal year 2008, the Company sold 1,000,000 shares of its common stock at $0.10 per share for $100,000 in cash.


On November 25, 2008, the Company’s Board of Directors authorized a Regulation D, Rule 504 stock sale and entered into a definitive agreement relating to the private placement of $7,500 of its securities through the sale of 15,000 shares of its common stock at $0.50 per share inclusive of a stock warrant to purchase 15,000 shares of its common stock exercisable at $1.00 expiring three (3) years from the date of issuance with Ryan Edington, the brother of Jerod Edington, the Vice-president and Chief Operating Officer of the Company.  The fair value of these warrants granted, estimated on the date of grant, was $3,300, which has been recorded as additional paid-in capital, using the Black-Scholes option-pricing model with the following weighted-average assumptions:


Expected option life (year)

 

 

 

 

3

 

Expected volatility

 

 

 

 

163.00%

 

Risk-free interest rate

 

 

 

 

3.34%

 

Dividend yield

 

 

 

 

0.00%

 


On January 23, 2009, the Company sold 250,000 shares of its common stock at $0.20 per share to Ron Kunisaki, the president of the company, for $50,000 in cash.


 

- 17 -


On July 25, 2009, pursuant to the Bridge Loan Agreement entered into by Triax Capital Management and Hydrodynex, Inc., dated July 24, 2008, Triax Capital Management exercised the conversion rights of the promissory note at the agreed rate of $0.25 per share. The original loan to the Company was in the amount of $4,000, and the 365 days of interest at 8% per annum of $320, equates to a conversion value of 17,280 shares.


On August 23, 2009, pursuant to the Bridge Loan Agreement entered into by Kyle Drexel and Hydrodynex, Inc., dated August 22, 2008, Mr. Drexel exercised the conversion rights of the promissory note at the agreed rate of $0.25 per share. The original loan to the Company was in the amount of $5,000, and the 365 days of interest at 8% per annum of $400, equates to a conversion value of 21,600 shares.


On September 26, 2009, the Company sold 30,000 shares of common stock at $0.25 per share for $7,500 in cash.


On November 9, 2009, the Company sold 140,000 shares of common stock at $0.25 per share for $35,000 in cash.


Stock option plan


On May 19, 2006, the Company’s board of directors approved the adoption of the “2006 Non-Qualified Stock Option and Stock Appreciation Rights Plan” (“2006 Plan”) by unanimous consent.  The 2006 Plan was initiated to encourage and enable officers, directors, consultants, advisors and key employees of the Company to acquire and retain a proprietary interest in the Company by ownership of its common stock.  A total of 1,000,000 of the authorized shares of the Company’s common stock may be subject to, or issued pursuant to, the terms of the plan.  The Company’s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.  Additionally, the Company’s policy is to issue new shares of common stock to satisfy stock option exercises.


On June 30, 2008, the Board of Director of the Company approved and granted stock options to purchase an aggregate of 85,000 shares of its common stock, par value $.001 per share (the “Common Stock”) at $0.25 per share expiring on June 30, 2013, five (5) years from the date of issuance, vested upon issuance.  On November 21, 2008, an officer and director of the Company resigned and surrendered his outstanding stock option to purchase 15,000 shares of the Company’s common stock to the Company. For the interim period ended December 31, 2009, the Company did not grant any stock options nor record any stock-based compensation.


The fair value of each option grant estimated on the date of grant uses the Black-Scholes option-pricing model with the following weighted-average assumptions:


 

 

 

 

June 30, 2008

 

Expected option life (year)

 

 

 

 

5

 

Expected volatility

 

 

 

 

85.000%

 

Risk-free interest rate

 

 

 

 

3.375%

 

Dividend yield

 

 

 

 

0.000%

 


The fair value of the stock options issued in June 2008 under the 2006 Plan using the Black-Scholes Option Pricing Model was $4,250 at the date of grant, all of which have being recognized as stock based compensation and so included in the statements of operations upon issuance.


The table below summarizes the Company’s stock option activity through December 31, 2009 :



- 18 -


 

 

 

Number of

 Option Shares

 

Exercise Price Range

 Per Share

 

Weighted 

Average Exercise Price

 

Fair Value

at Date of Grant

 

Aggregate

 Intrinsic

 Value

 


Balance, June 30, 2007

 

 

-

 

 

 

$

-

 

 

 

$

-

 

 

 

-

 

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

85,000

 

 

 

 

0.25

 

 

 

 

0.25

 

 

 

4,250

 

 

 

 

-

 

 

Canceled

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

 

-

 

 

Exercised

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

 

-

 

 

Expired

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

 

-

 

 

Balance, June 30, 2008

 

 

85,000

 

 

 

 

0.25

 

 

 

 

0.25

 

 

 

4,250

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

 

-

 

 

Canceled

 

 

(15,000

 

 

 

0.25

 

 

 

 

0.25

 

 

 

-

 

 

 

 

-

 

 

Exercised

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

 

-

 

 

Expired

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

 

-

 

 

Balance, June 30, 2009

 

 

70,000

 

 

 

$

0.25

 

 

 

$

0.25

 

 

 

4,250

 

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

 

-

 

 

Canceled

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Exercised

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

 

-

 

 

Expired

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

 

-

 

 

Balance, December 31, 2009

 

 

70,000

 

 

 

$

0.25

 

 

 

$

0.25

 

 

 

4,250

 

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and exercisable, December 31, 2009

 

 

70,000

 

 

 

$

0.25

 

 

 

$

0.25

 

 

 

4,250

 

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unvested, December 31, 2009

 

 

-

 

 

 

$

-

 

 

 

$

-

 

 

 

-

 

 

 

$

-

 

 


The following table summarizes information concerning outstanding and exercisable stock options as of December 31, 2009:


 

 

Options Outstanding

 

Options Exercisable

 

Range of Exercise Prices

 

Number Outstanding

 

Average Remaining Contractual Life  (in years)

 

Weighted Average Exercise Price

 

Number Exercisable

 

Average Remaining Contractual Life  (in years)

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$0.25

 

 

70,000

 

 

4.0

 

$

0.25

 

 

70,000

 

 

4.0

 

$

0.25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$0.25

 

 

70,000

 

 

4.0

 

$

0.25

 

 

70,000

 

 

4.0

 

$

0.25

 


As of December 31, 2009, there were 930,000 shares of stock options available for issuance under the 2006 Plan.


Warrants


(i) In connection with the issuance of convertible notes payable issued between July 24, 2008 and August 23, 2008, the Company issued warrants to purchase 12,000 shares of its common stock in aggregate to the note holder with an exercise price of $1.00 per share and expiring three (3) years from the date of issuance, all of which have been earned upon issuance. The Company determined the fair value of the warrants issued was $2,640 using the Black-Scholes Option Pricing Model.


(ii) In connection with the sale of 15,000 shares of its common stock on November 25, 2008, the Company issued warrants to purchase 15,000 shares of its common stock to the investor with an exercise price of $1.00 per share and expiring three (3) years from the date of issuance, all of which have been earned upon issuance. Company determined the fair value of the warrants issued was $3,300 using the Black-Scholes Option Pricing Model.


The table below summarizes the Company’s warrants activity though December 31, 2009:


 

- 19 -



 

 

 

Number of

 Warrant Shares

 

Exercise Price Range

 Per Share

 

Weighted 

Average Exercise Price

 

Fair Value at Date of Issuance

 

Aggregate

 Intrinsic

 Value

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, June 30, 2008

 

 

-

 

 

 

$

-

 

 

 

$

-

 

 

$

-

 

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

27,000

 

 

 

 

1.00

 

 

 

 

1.00

 

 

 

5,940

 

 

 

 

-

 

 

Canceled

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Exercised

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Expired

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Balance, June 30, 2009

 

 

27,000

 

 

 

$

1.00

 

 

 

$

1.00

 

 

$

5,940

 

 

 

$   

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Canceled

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Exercised

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Expired

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Balance, December 31, 2009

 

 

27,000

 

 

 

$

1.00

 

 

 

$

1.00

 

 

$

5,940

 

 

 

$   

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earned and exercisable, December 31, 2009

 

 

27,000

 

 

 

$

1.00

 

 

 

$

1.00

 

 

$

5,940

 

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unvested, December 31, 2009

 

 

-

 

 

 

$

1.00

 

 

 

$

1.00

 

 

$

-

 

 

 

$

-

 

 


The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2009:


 

 

Warrants Outstanding

 

Warrants Exercisable

 

Range of Exercise Prices

 

Number Outstanding

 

Average Remaining Contractual Life  (in years)

 

Weighted Average Exercise Price

 

Number Exercisable

 

Average Remaining Contractual Life  (in years)

 

Weighted Average Exercise Price

 

$1.00

 

 

27,000

 

 

2.00

 

$

1.00

 

 

27,000

 

 

2.00

 

$

1.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$1.00

 

 

27,000

 

 

2.00

 

$

1.00

 

 

27,000

 

 

1.00

 

$

1.00

 


NOTE 9 – RELATED PARTY TRANSACTIONS


Advances from stockholder


Jerod Edington, formerly President and CEO of the Company and currently the Vice President and Chief Operating Officer as well as a director has provided advances to the Company for its working capital. These advances bear no interest, have no formal repayment terms and are due upon demand. Detailed advances are as follows:


On June 12, 2008, then President. CEO, and a director of the Company advanced the Company $2,000 to be repaid on or before December 31, 2008, which was fully repaid on July 24, 2008.


During the quarter ended December 31, 2008, Mr. Edington, then President, CEO and a director of the Company advanced the Company $1,750 to be repaid on or before January 31, 2009.  During the quarter ended March 31, 2009, Mr. Edington, advanced the Company an additional $10,225 without interest, to be repaid on or before March 31, 2009.  Both of these advances were fully repaid as of February 6, 2009.


Notes payable to stockholder


Jerod Edington, the Vice President and Chief Operating Officer of the Company loaned the Company $3,440 with no interest on September 3, 2009, to be repaid on or before December 31, 2009.  Jerod Edington agreed to an extension of this note to June 30, 2010.


Consulting services from Vice President, Chief Operating Officer, Director and Stockholder


The table below shows consulting services provided by the Vice President, Chief Operating Officer, and Director for the interim period ended December 31, 2009 and 2008 is as follows:



 

- 20 -



 

 

 

December 31, 2009

 

 

December 31, 2008

 

Consulting services received and consulting fees booked

 

$

7,500

 

 

$

15,000

 

 

 

 

 

 

 

 

 

 

TOTAL

 

$

7,500

 

 

$

15,000

 


These consulting fees are still outstanding and included in the accrued expenses for related party on the Company Balance Sheet.  The Company currently has $37,600 total in accrued expenses for related parties.


NOTE 10 – SUBSEQUENT EVENTS


The Company has evaluated all events that occur after the balance sheet date of December 31, 2009 through February 5, 2010, the date when the financial statements were issued to determine if they must be reported.  The Management of the Company determined that there were no reportable subsequent events to be disclosed.


As of January 13, 2010, the Company repaid Vice President and Chief Operating Officer, Jerod Edington, $440 of principal on the $3,440 note payable dated September 3, 2009.  The outstanding note payable balance is now $3,000.



- 21 -


Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations


CAUTIONARY STATEMENT FOR FORWARD-LOOKING STATEMENTS


THIS QUARTERLY REPORT ON FORM 10-Q CONTAINS “FORWARD-LOOKING STATEMENTS” WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND INVOLVE A HIGH DEGREE OF RISK AND UNCERTAINTY. ALL STATEMENTS, OTHER THAN STATEMENTS OF HISTORICAL FACTS, INCLUDED IN OR INCORPORATED BY REFERENCE INTO THIS FORM 10-Q ARE FORWARD-LOOKING STATEMENTS. IN ADDITION, WHEN USED IN THIS DOCUMENT, THE WORDS “ANTICIPATE,” “ESTIMATE,” “PROJECT,” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS. OUR ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE PROJECTED IN THE FORWARD-LOOKING STATEMENTS DUE TO RISKS AND UNCERTAINTIES THAT EXIST IN OUR OPERATIONS. THESE FORWARD-LOOKING STATEMENTS ARE SUBJECT TO CERTAIN RISKS, UNCERTAINTIES AND ASSUMPTIONS INCLUDING AMONG OTHERS, THE RISK THAT OUR PRODUCT DEVELOPMENT PROGRAMS WILL NOT PROVE SUCCESSFUL, THAT WE WILL NOT BE ABLE TO OBTAIN FINANCING TO COMPLETE ANY FUTURE PRODUCT DEVELOPMENT, THAT OUR PRODUCTS WILL NOT PROVE COMPETITVE IN THEIR MARKETS. THESE RISKS AND OTHERS ARE MORE FULLY DESCRIBED IN OUR ANNUAL REPORT ON FORM 10-K. SHOULD ONE OR MORE OF THESE RISKS OR UNCERTAINTIES MATERIALIZE, OR SHOULD UNDERLYING ASSUMPTIONS PROVE INCORRECT, ACTUAL RESULTS MAY VARY MATERIALLY FROM THOSE ANTICIPATED, ESTIMATED OR PROJECTED.


ALTHOUGH WE BELIEVE THAT THE EXPECTATIONS INCLUDED IN SUCH FORWARD-LOOKING STATEMENTS ARE REASONABLE, WE CANNOT GIVE ANY ASSURANCES THAT THESE EXPECTATIONS WILL PROVE TO BE CORRECT. WE UNDERTAKE NO OBLIGATION TO PUBLICLY RELEASE THE RESULT OF ANY REVISIONS TO SUCH FORWARD-LOOKING STATEMENTS THAT MAY BE MADE TO REFLECT EVENTS OR CIRCUMSTANCES AFTER THE DATE HEREOF OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.


The following discussion and analysis should be read in conjunction with our financial statements and the notes thereto appearing in Part I, Item 1.


General


Hydrodynex, Inc. was organized under the laws of the state of Nevada on May 12, 2006 and is doing business as a marketer of AO-System ® water treatment units.  We intend to manufacture or assemble and distribute the AO-Systems products in North America under the terms of our License agreement with Hydrosystemtechnik GmbH.  Since commencement of operations in 2006, substantially all of our efforts to date have been devoted to and limited primarily to organization, initial capitalization, market research, producing marketing materials and a website, securing a marketing agreement, preparing a comprehensive business and operating plan, evaluating the regulatory requirements to sell water treatment systems in the U.S., Canada and Mexico, and undertaking a marketing feasibility study.  Extensive research has been done on competing technologies and the water contaminants that most adversely affect water systems at the present time.  Legionella protection is the strongest market opportunity identified by Hydrodynex to date.  We will make Legionella our primary target market because of its wide prevalence and the high percentage of death resulting from infection.


Under our license agreement, as amended, with our licensor Hydrosystemtechnik, we paid two non-refundable license fees in the amount of €10,000 ($14,892) in 2007, and €20,000 ($26,486) in 2009, both of which are non–refundable and creditable to future royalty payments.  A third license fee in the amount of €20,000 will be due upon certification and approval of the AO-Systems® by the U.S. Environmental Protection Agency for commercial sales in the United States.


Under the terms of our license agreement with our licensor Hydrosystemtechnik, we paid a 50% deposit for the purchase of a test model AO-Systems® unit in the amount of € 17,625 ($ 26,991) in 2008.  We were required, under the original license agreement with our licensor, to make the complete purchase of a unit by September 3, 2008.  Under the terms of the amended license agreement dated August 30, 2008, and with additional extensions granted, Hydrosystemtechnik agreed in writing to an extension of the purchase completion date for our test AO-Systems® unit from September 3, 2008 to November 30, 2009.  Although this deadline has passed, the licensor has not reduced our license to a non-exclusive status at this time, but could do so at any time..


Under the terms of our license agreement with our licensor Hydrosystemtechnik we are required to gain approval from the Environmental Protection Agency by March 3, 2010, thirty months after the effective date of our license agreement.  The verification and certification process leading to such approval involves extensive testing and is an expensive process.  We will have to raise additional capital to pay for the independent verification and certification process leading to approval.  We have made contact with staff at NSF, received price quotes, and met with NSF representatives in person, but we have not begun the testing process to initiate the verification and certification process..  We are currently awaiting additional investment capital to pay for the second 50% payment of the test AO-Systems® reactor that we have ordered from our licensor, and the $10,000



- 22 -


deposit required for protocol development so that we can begin the testing process with NSF.  If we fail to meet the deadline for approval from the EPA for the AO-Systems® water disinfection technology, which appears practically certain to occur since we have not begun the necessary testing process, if our licensor does not agree to an extension of this contractual requirement, our license will become non-exclusive and our licensor could terminate the amended license agreement.


We have not sold any product to date and have generated no revenues from operations.


Our plan of operation for the next 12 months, assuming sufficient capital resources are available, will be the execution of our strategic business plan.   Hydrodynex intends to operate in three phases as follows:


Phase 1: Finalization of the Strategic Marketing Plan, initial start-up capital realization through a second private stock offering, completing purchase of AO System ® unit from our licensor, Hydrosystemtechnik, undertaking independent testing, securing EPA and State certification, and hiring/training sales and technical personnel.


Phase 2: Initiation of marketing and sales activities in selected markets in North America (U.S., Canada, and Mexico).  Full scale commercialization of the AO-System ®, including industrialization and after-sale service agreements, for the markets covered by Hydrodynex.  As part of its effort to commercialize the AO-System ®, Hydrodynex plans to offer mobile systems which may use a film pouch packaging system.  


Phase 3:  Set-up manufacturing in the U.S. when it becomes a viable, profit-increasing option.


We will need to raise a minimum of $400,000 to complete the first phase of our plan of operations and $2,000,000 to complete the second phase, for a total of $2,400,000 to implement both phases of our business plan.


Provided that we can raise additional capital, our projected monthly rate of expenditure is estimated at $4,000 for general and administrative costs.  We anticipate that supporting our operations and implementing Phase I of our business plan for the next 12 months will require a minimum of $400,000.  This includes approximately $30,000 for accounting, legal and auditing fees.  The balance of the funds would be utilized for independent technology verification testing, purchase of AO-System®(s) for verification testing, marketing materials, advertising, insurance, employee training, travel, office lease, licenses, shipping and import costs, employee salary, and other budget costs.


Product Research and Development Plans


We do not plan to engage in any research and development at this time.  The product has been developed by our licensor, Hydrosystemtechnik, GmbH and is ready for sale to the consumer.


Results of Operations


On October 6, 2009, upon the notification by our management and in consultation with Li & Company, PC, our independent registered public accounting firm about certain accounting misstatements in our previously issued financial statements for the fiscal year ended June 30, 2008 and quarterly periods ended September 30, 2008, December 31, 2008 and March 31, 2009.  Upon the notification by our management of such misstatements, our Board of Directors concluded that our previously issued financial statements for the fiscal year ended June 30, 2008 and quarterly periods ended September 30, 2008, December 31, 2008 and March 31, 2009, should no longer be relied upon due to certain accounting misstatements in those financial statements.  Such misstatements include, but are not limited to, the following: (i) to separate prepaid patents application costs from deferred license fees, (ii) to reclassify foreign currency transaction (gain) loss from the payment of license fees payable denominated in € previously recorded as deferred license fees, (iii) to record second and third license fee installment payments under exclusive license agreement not booked, (iv) to adjust license fees payable denominated in Euros to reflect the exchange rate at June 30, 2009.


Net cash used in operating activities during the six months ended December 31, 2009 was $42,344 resulting in a net loss of $21,437 as compared to net cash used in operating activities during the six months ended December 31, 2008 of $44,680 resulting in a net loss of $47,169.


Liquidity and Capital Resources


As of December 31, 2009, we had $8,892 in cash. We do not have any available lines of credit.  We have financed our operations from the proceeds from private placements of equity securities, through bridge loans, and through loans from an officer.  


In a private placement offering that closed on September 30, 2007, we raised a total of $100,000 from sale of common stock at $0.10 per share pursuant to Rule 504 of Regulation D of the Securities Act of 1933 from 40 investors.


 

- 23 -


In August 2008, we raised $12,000 and issued a convertible promissory note in that amount and 12,000 three year warrants exercisable at $1.00 per share to three investors initially planned as part of a $50,000 bridge loan.  Subsequently we decided to terminate the bridge loan offering after the receipt of $12,000.  The convertible promissory note earned interest at a rate of 8% per annum and had a maturity date one year from the date of issuance.  Under the terms of the note, it was to convert automatically into common shares at $0.50 per share upon the closing of an equity financing of at least $400,000 (including funds received under the bridge loan) prior to the maturity date or holders may convert their debt into shares at $0.25 per share if such a financing does not close prior to the maturity date of the convertible promissory note,.  On July 25, 2009 and August 23, 2009, we issued 17,280 and 21,600 shares of common stock, respectively, to two of the convertible bridge loan holders.  Triax Capital Management converted debt in the amount of $4,000 and accrued interest of $400  and Kyle Drexel converted debt in the amount of $4,000 and accrued interest of $320.  In September 2009, the third convertible promissory note investor was repaid in full $3,240, which includes $3,000 in principal and interest at 8% per annum of $240.


In November 2008, we raised $7,500 though the sale of shares and warrants in a private transaction.  Shares in this transaction were sold at $0.50 per share for a total of 15,000 shares issued, and three year warrants exercisable into 15,000 shares at $1.00 per share were also issued.


On January 23, 2009, we raised $50,000 by securities sold in a private transaction.  Shares in this transaction were sold at $0.20 for a total of 250,000 shares issued.  Ronald Kunisaki, subsequently appointed as our new President and Chief Executive Officer, was the purchaser in this private placement.


On September 26, 2009, we issued 30,000 shares of our common stock at $0.25 per share to a single, accredited investor for gross proceeds of $7,500.  The purchaser in the private placement was Marycliff Investment Corp.


On November 9, 2009, we issued 140,000 shares of our common stock at $0.25 per share to a single, accredited investor for gross proceeds of $35,000.  The purchaser in the private placement was Peter Swan Investment-Consulting, Ltd.

The proceeds from these sales of unregistered securities were used to pay outstanding debt.  We have exhausted the proceeds from these sales of our stock due to the payment of accounts payable.


We will need to raise additional capital or generate revenue by March 2010 or curtail our operations.  We intend to sell additional shares of common stock or units consisting of common stock and stock purchase warrants in a private placement offering to secure additional capital to fund Phase I of our strategic plan.  The amount we would like to raise is $750,000.


We plan to finance our needs principally from future private placement equity offerings.


We do not have sufficient capital to carry on operations past March 2010, but we plan to secure additional capital by the additional sale of common stock in a private offering or executing a bridge loan to finance our plan of operation for at least the next twelve months. However, this is a forward-looking statement, and there may be changes that could consume available resources before such time. Our long term capital requirements will depend on many factors, including the eventual reporting company costs, public relations fees, technology verification costs, among others.


We are pursuing potential equity financing, sub-licensing and other collaborative arrangements that may generate additional capital for us.  We cannot be certain that we will generate sufficient additional capital or revenues, if any, to fund our operations beyond March 2010, that any future equity financings will be successful, or that other potential financings through bank borrowings, debt or equity offerings, or otherwise, will be available on acceptable terms or at all.


We can provide no assurance to investors we will be able to find such financing when such funding is required.  Obtaining additional financing would be subject to a number of factors, including investor acceptance of our product and our business model.  Furthermore, there is no assurance that we will not incur further debt in the future, that we will have sufficient funds to repay our future indebtedness, or that we will not default on our future debts, thereby jeopardizing our business viability. Finally, we may not be able to borrow or raise additional capital in the future to meet our needs or to otherwise provide the capital necessary to maintain our operations, which might result in the loss of some or all of your investment in our common stock.


We cannot assure you that we will generate sufficient additional capital or revenues, if any, to fund our operations beyond March 2010, that any future equity financings will be successful, or that other potential financings through bank borrowings, debt or equity offerings, or otherwise, will be available on acceptable terms or at all.  If we are unable to raise additional capital when necessary, we will have to curtail or cease operations.


New Accounting Pronouncements


In June 2003, the Securities and Exchange Commission (“SEC”) adopted final rules under Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”), as amended by SEC Release No. 33-9072 on October 13, 2009.  Commencing with its annual report for

 

- 24 -


the fiscal year ending December 31 2010, the Company will be required to include a report of management on its internal control over financial reporting. The internal control report must include a statement


·  

of management’s responsibility for establishing and maintaining adequate internal control over its financial reporting;


·  

of management’s assessment of the effectiveness of its internal control over financial reporting as of year end; and


·  

of the framework used by management to evaluate the effectiveness of the Company’s internal control over financial reporting.


Furthermore, it is required to file the auditor’s attestation report separately on the Company’s internal control over financial reporting on whether it believes that the Company has maintained, in all material respects, effective internal control over financial reporting.


In June 2009, the FASB approved the “FASB Accounting Standards Codification” (the “Codification”) as the single source of authoritative nongovernmental U.S. GAAP to be launched on July 1, 2009.  The Codification does not change current U.S. GAAP, but is intended to simplify user access to all authoritative U.S. GAAP by providing all the authoritative literature related to a particular topic in one place.  All existing accounting standard documents will be superseded and all other accounting literature not included in the Codification will be considered non-authoritative. The Codification is effective for interim and annual periods ending after September 15, 2009.


In August 2009, the FASB issued the FASB Accounting Standards Update No. 2009-04 “Accounting for Redeemable Equity Instruments - Amendment to Section 480-10-S99” which represents an update to section 480-10-S99, distinguishing liabilities from equity, per EITF Topic D-98, Classification and Measurement of Redeemable Securities.  The Company does not expect the adoption of this update to have a material impact on its consolidated financial position, results of operations or cash flows.


In August 2009, the FASB issued the FASB Accounting Standards Update No. 2009-05 “Fair Value Measurement and Disclosures Topic 820 – Measuring Liabilities at Fair Value”, which provides amendments to subtopic 820-10, Fair Value Measurements and Disclosures – Overall, for the fair value measurement of liabilities.  This update provides clarification that in circumstances in which a quoted price in an active market for the identical liability is not available, a reporting entity is required to measure fair value using one or more of the following techniques: 1. A valuation technique that uses: a. The quoted price of the identical liability when traded as an asset b. Quoted prices for similar liabilities or similar liabilities when traded as assets. 2. Another valuation technique that is consistent with the principles of topic 820; two examples would be an income approach, such as a present value technique, or a market approach, such as a technique that is based on the amount at the measurement date that the reporting entity would pay to transfer the identical liability or would receive to enter into the identical liability. The amendments in this update also clarify that when estimating the fair value of a liability, a reporting entity is not required to include a separate input or adjustment to other inputs relating to the existence of a restriction that prevents the transfer of the liability. The amendments in this update also clarify that both a quoted price in an active market for the identical liability when traded as an asset in an active market when no adjustments to the quoted price of the asset are required are Level 1 fair value measurements.  The Company does not expect the adoption of this update to have a material impact on its consolidated financial position, results of operations or cash flows.


In September 2009, the FASB issued the FASB Accounting Standards Update No. 2009-08 “Earnings Per Share – Amendments to Section 260-10-S99”,which represents technical corrections to topic 260-10-S99, Earnings per share, based on EITF Topic D-53, Computation of Earnings Per Share for a Period that includes a Redemption or an Induced Conversion of a Portion of a Class of Preferred Stock and EITF Topic D-42, The Effect of the Calculation of Earnings per Share for the Redemption or Induced Conversion of Preferred Stock. The Company does not expect the adoption of this update to have a material impact on its consolidated financial position, results of operations or cash flows.


In September 2009, the FASB issued the FASB Accounting Standards Update No. 2009-09 “Accounting for Investments-Equity Method and Joint Ventures and Accounting for Equity-Based Payments to Non-Employees”.  This update represents a correction to Section 323-10-S99-4, Accounting by an Investor for Stock-Based Compensation Granted to Employees of an Equity Method Investee. Additionally, it adds observer comment Accounting Recognition for Certain Transactions Involving Equity Instruments Granted to Other Than Employees to the Codification. The Company does not expect the adoption to have a material impact on its consolidated financial position, results of operations or cash flows.


In September 2009, the FASB issued the FASB Accounting Standards Update No. 2009-12 “Fair Value Measurements and Disclosures Topic 820 – Investment in Certain Entities That Calculate Net Assets Value Per Share (or Its Equivalent)”, which provides amendments to Subtopic 820-10, Fair Value Measurements and Disclosures-Overall, for the fair value measurement of investments in certain entities that calculate net asset value per share (or its equivalent). The amendments in this update permit, as a practical expedient, a reporting entity to measure the fair value of an investment that is within the scope of the amendments in this update on the basis of the net asset value per share of the investment (or its equivalent) if the net asset value of the investment (or its equivalent) is calculated in a manner consistent with the measurement principles of Topic 946 as of the reporting entity’s

 

- 25 -


measurement date, including measurement of all or substantially all of the underlying investments of the investee in accordance with Topic 820. The amendments in this update also require disclosures by major category of investment about the attributes of investments within the scope of the amendments in this update, such as the nature of any restrictions on the investor’s ability to redeem its investments a the measurement date, any unfunded commitments (for example, a contractual commitment by the investor to invest a specified amount of additional capital at a future date to fund investments that will be make by the investee), and the investment strategies of the investees. The major category of investment is required to be determined on the basis of the nature and risks of the investment in a manner consistent with the guidance for major security types in U.S. GAAP on investments in debt and equity securities in paragraph 320-10-50-1B. The disclosures are required for all investments within the scope of the amendments in this update regardless of whether the fair value of the investment is measured using the practical expedient. The Company does not expect the adoption to have a material impact on its consolidated financial position, results of operations or cash flows.


Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying consolidated financial statements.


Critical Accounting Policies and Estimates


This discussion and analysis of our financial condition and results of operations are based on our financial statements that have been prepared under accounting principles generally accepted in the United States of America. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. All significant accounting policies have been disclosed in Note 2 to the financial statements included in our Form 10-K.  Our critical accounting policies are:


Revenue recognition


The Company follows the guidance of the United States Securities and Exchange Commission’s Staff Accounting Bulletin (“SAB”) No. 101 “Revenue Recognition” (“SAB No. 101”), as amended by SAB No. 104 (“SAB No. 104”) for revenue recognition.  The Company recognizes revenue when it is realized or realizable and earned less estimated future doubtful accounts.  The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.


The Company will derive its revenue from sales contracts with customers with revenues being generated upon the shipment of goods upon the Company commencing operations.  Persuasive evidence of an arrangement is demonstrated via invoice, product delivery is evidenced by warehouse shipping log as well as a signed bill of lading from the trucking company or third party carrier and title transfers upon shipment, based on free on board (“FOB”) warehouse; the sales price to the customer is fixed upon acceptance of the purchase order and there is no separate sales rebate, discount, or volume incentive.


Foreign currency transactions


The Company has adopted the guidelines as set out in Statement of Financial Accounting Standards No. 52 “Foreign currency translation” (“SFAS No. 52”) for Foreign currency transactions.  Pursuant to Paragraph 15 of SFAS No. 52, foreign currency transactions are transactions denominated in a currency other than U.S. Dollar, the Company’s functional currency.  Foreign currency transactions may produce receivables or payables that are fixed in terms of the amount of foreign currency that will be received or paid.  A change in exchange rates between the functional currency and the currency in which a transaction is denominated increases or decreases the expected amount of functional currency cash flows upon settlement of the transaction. That increase or decrease in expected functional currency cash flows is a foreign currency transaction gain or loss that generally shall be included in determining net income for the period in which the exchange rate changes. Likewise, a transaction gain or loss (measured from the transaction date or the most recent intervening balance sheet date, whichever is later) realized upon settlement of a foreign currency transaction generally shall be included in determining net income for the period in which the transaction is settled. The exceptions to this requirement for inclusion in net income of transaction gains and losses pertain to certain intercompany transactions and to transactions that are designated as, and effective as, economic hedges of net investments and foreign currency commitments.  Pursuant to Paragraph 16, of SFAS No. 52, for other than forward exchange contracts as defined in paragraphs 17-19 of SFAS No. 52, the following shall apply to all foreign currency transactions of an enterprise and its investees: (a) At the date the transaction is recognized, each asset, liability, revenue, expense, gain, or loss arising from the transaction shall be measured and recorded in the functional currency of the recording entity by use of the exchange rate in effect at that date as defined in paragraphs 26-28 of SFAS No. 52; and (b) At each balance sheet date, recorded balances that are denominated in a currency other than the functional currency of the recording entity shall be adjusted to reflect the current exchange rate.


 

- 26 -


Item 3.  Quantitative and Qualitative Disclosures About Market Risk


Not required

 

Item 4.  Controls and Procedures


Evaluation of Disclosure Controls and Procedures


In connection with the preparation of this Quarterly Report on Form 10-Q, an evaluation was carried out by our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of December 31, 2009.  Based on that evaluation, our principal executive officer and our principal financial officer have concluded that our disclosure controls and procedures were not effective as of December 31, 2009.  The material weaknesses we identified in our annual report on Form 10-K for our fiscal year ending June 30, 2009 filed on October 13, 2009 have not been remedied due to our lack of sufficient capital resources.


Changes in Internal Control Over Financial Reporting

As of December 31, 2009, there have been no changes in internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) during the quarter ended December 31, 2009, that materially affected, or are reasonably likely to materially affect, our company’s internal control over financial reporting.



- 27 -


PART II. OTHER INFORMATION


Item 1.  Legal Proceedings


There have been no material changes from the disclosure provided in Part 1, Item 1A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2009.

 

Item 1A.  Risk Factors


We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.


Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds 


On November 9, 2009, we issued 140,000 shares of our common stock at $0.25 per share to a single, accredited investor for gross proceeds of $35,000.  The purchaser in the private placement was Peter Swan Investment-Consulting, Ltd.  In conjunction with the private placement, there were no fees, commissions or professional fees for services payable.  The placement was undertaken by the officers of Hydrodynex.  The private placement of these securities was exempt from registration under pursuant to Section 4(2) of the Securities Act of 1933, as amended.

The proceeds from these sales of unregistered securities were used to paying outstanding debt.  We have exhausted the proceeds from these sales of our stock due to the payment of accounts payable.


Item 3.  Defaults Upon Senior Securities


None.


Item 4.  Submission of Matters to a Vote of Security Holders


None.


Item 5.  Other Information


None.



- 28 -


Item 6.  Exhibits 


Exhibit Number

Description of Exhibit

 

 

3.1

Articles of Incorporation of Registrant(1)

 

 

3.2

Bylaws of Registrant(1)

 

 

4.1

Form of  2008 Promissory Notes and Warrant Purchase Agreement (2)

 

 

4.2

Form of 2008 Common Stock Warrant Purchase Agreement (2)

 

 

4.3

Form of 2009 Stock Purchase Agreement (3)

 

 

31.1

Certification of Principal Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended.

 

 

31.2

Certification of Principal Financial Officer pursuant to Rule 13a-14 and Rule 15d 14(a), promulgated under the Securities and Exchange Act of 1934, as amended.

 

 

32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer).

 

 

32.2

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Financial Officer).


(1)

Filed with the Securities and Exchange Commission on June 30, 2008 as an exhibit, numbered as indicated above, to the Registrant’s registration statement on Form S-1 (file no. 333-152052), which exhibit is incorporated herein by reference.

(2)

Filed with the Securities and Exchange Commission on April 22, 2009, as an exhibit, numbered as indicated above, to the Registrant’s Annual report on Form 10-K/A2 (file no. 000-53506), which exhibit is incorporated herein by reference.

(3)

Filed with the Securities and Exchange Commission on September 28, 2009, as an exhibit, numbered as indicated above, to the Registrant’s Form 8-K (file no. 000-53506), which exhibit is incorporated herein by reference.




SIGNATURES


In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 

Hydrodynex, Inc.

 

 

February 11, 2010

By:  

/s/ Ronald Kunisaki

 

Ronald Kunisaki

President and Chief Executive Officer

(Principal Executive Officer)

 

 

February 11, 2010

By:  

/s/ Richard Kunisaki

 

Richard Kunisaki

Chief Financial Officer and Treasurer

(Principal Financial and Accounting Officer)




- 29 -